Description: Microba Life Sciences Limited operates as a gut microbiome analysis company in Australia. It offers Insight, a test for the metagenomic analysis of the gut microbiome; and bespoke health management solutions for partners and practitioners to improve patient care. The company was incorporated in 2017 and is based in Brisbane, Australia.
Home Page: microba.com
MAP Technical Analysis
MainStay Funds
,
Phone:
800-624-6782
Officers
| Name | Title |
|---|---|
| Dr. Luke Reid | Chief Exec. Officer |
| Prof. Gene Tyson | Co-Founder & Non-Exec. Director |
| Mr. James Heath | CFO & Company Sec. |
| Prof. Philip Hugenholtz | Co-Founder & Chair of Scientific Advisory Board |
| Mr. Yao Liu | Chief Technology Officer |
| Prof. Lutz Krause | Chief Scientific Officer |
| Mr. Drew Webb | Chief Marketing Officer |
| Prof. Trent Munro | Sr. VP of Therapeutics |
| Dr. Nicola Angel | Head of Laboratory Operations |
| Mr. Bernie Woodcroft | Sr. VP of Platform Solutions |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.2724 |
| Price-to-Sales TTM: | 24.869 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |